UK markets closed
NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,284.54 +83.27 (+0.48%) CRUDE OIL
82.47 -0.34 (-0.41%) GOLD FUTURES
2,340.60 +2.20 (+0.09%) DOW
38,001.53 -459.39 (-1.19%) Bitcoin GBP
51,595.37 -174.29 (-0.34%)
JCR Pharmaceuticals Co., Ltd. (4552.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
At close: 03:15PM JST
| Previous close | 813.00 |
| Open | 810.00 |
| Bid | 792.00 x 0 |
| Ask | 795.00 x 0 |
| Day's range | 793.00 - 813.00 |
| 52-week range | 778.00 - 1,567.00 |
| Volume | |
| Avg. volume | 748,909 |
| Market cap | 98.967B |
| Beta (5Y monthly) | -0.01 |
| PE ratio (TTM) | 18.55 |
| EPS (TTM) | 42.76 |
| Earnings date | 10 May 2024 |
| Forward dividend & yield | 20.00 (2.46%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | 1,700.00 |
Business WireJCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
HYOGO, Japan, March 19, 2024--JCR Pharmaceuticals announces achievement of milestone using J-Brain Cargo® for neurodegenerative disease in research collaboration with Alexion.
Business WireJCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
HYOGO, Japan, February 29, 2024--JCR Pharmaceuticals celebrates Rare Disease Day 2024 and highlights its commitment to the rare disease community.
Business WireJCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
HYOGO, Japan, February 14, 2024--JCR announced the presentation of several datasets demonstrating the potential benefits of its investigational LSD therapies at the WORLDSymposium™.
© 2024 Yahoo. All rights reserved.